Immunohistochemical profiling of four transcriptional regulators in SCLC, i.e., ASCL1, NEUROD1, POU2 F3, and YAP1 could be performed to stratify patients who can specifically benefit from 753b. Here, ASCL1 is linked to small cell lung carcinoma.